中文名 | A-804598 |
英文名 | A-804598 |
别名 | A-804598游离态 化合物CZC25146 |
英文别名 | CS-2234 A 804598 A-804598 1-cyano-2-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine 1-CYANO-2-[(1S)-1-PHENYLETHYL]-3-QUINOLIN-5-YLGUANIDINE 2-Cyano-1-[(1S)-1-phenylethyl]-3-(5-quinolinyl)guanidine N-Cyano-N′′-[(1S)-1-phenylethyl]-N′-5-quinolinyl-guanidine Guanidine, N-cyano-N''-[(1S)-1-phenylethyl]-N'-5-quinolinyl- |
CAS | 1125758-85-1 |
化学式 | C19H17N5 |
分子量 | 315.37 |
密度 | 1.17±0.1 g/cm3(Predicted) |
沸点 | 498.0±47.0 °C(Predicted) |
溶解度 | DMSO: 溶解10mg/mL,澄清 |
酸度系数 | 4.52±0.12(Predicted) |
存储条件 | Keep in dark place,Sealed in dry,2-8°C |
外观 | 粉末 |
颜色 | white to beige |
体外研究 | Pre-incubation with A-804598 (0.1-10 μM; 1 hour) significantly attenuates BzATP-induced cell loss in a concentration-dependent manner. 3 μM A-804598 exhibits the greatest protective effect against BzATP-induced cytotoxicity. Cell Cytotoxicity Assay Cell Line: microglial cell Concentration: 0.1, 0.3, 1, 3, 10 μM Incubation Time: 1 hour Result: Protected against BzATP-induced cytotoxicity in both inactivated and activated microglia. |
体内研究 | A chroni treatment with A-804598 (intraperitoneal injection; 30 mg/kg; five times a week) decreases the expression of LC3B-II and SQSTM1/p62 in lumbar spinal cord at end stage of disease. Animal Model: Adult B6.Cg-Tg (SOD1-G93A) 1Gur/J female mice Dosage: 30 mg/kg Administration: Intraperitoneal injection; five times a week Result: Decreased SQSTM1/p62 expression. |
危险品标志 | T - 有毒物品 |
风险术语 | 25 - 吞食有毒。 |
安全术语 | 45 - 若发生事故或感不适,立即就医(可能的话,出示其标签)。 |
危险品运输编号 | UN 2811 6.1 / PGIII |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.171 ml | 15.854 ml | 31.709 ml |
5 mM | 0.634 ml | 3.171 ml | 6.342 ml |
10 mM | 0.317 ml | 1.585 ml | 3.171 ml |
5 mM | 0.063 ml | 0.317 ml | 0.634 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!